id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0453-0035,FDA,FDA-2005-N-0453,"Determination and Feedback Letter from FDA/CDER to Ciba Specialty Chemicals Corporation (Ciba) (Morgan, Lewis & Bockius LLP) re Time and Extent Application (TEA) Bemotrizinol for use in Over-the-Counter (OTC) Sunscreen",Other,Letter(s),2014-11-14T05:00:00Z,2014,11,2014-11-14T05:00:00Z,,2014-11-14T20:28:13Z,,0,0,090000648192f333
FDA-2005-N-0453-0034,FDA,FDA-2005-N-0453,"Initial Determination and Feedback Letter from FDA/CDER to Ciba Specialty Chemicals Corporation (Ciba) (Morgan, Lewis & Bockius LLP) re Time and Extent Application (TEA) Bemotrizinol  for use in Over-the-Counter (OTC) Sunscreens",Other,,2014-11-13T00:00:00Z,2014,11,,,2014-11-14T16:27:35Z,,0,1,090000648192d191
FDA-2005-N-0453-0028,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 8 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:28:36Z,,0,0,0900006481902a13
FDA-2005-N-0453-0022,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 2 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:20:46Z,,0,0,09000064819029b7
FDA-2005-N-0453-0025,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 5 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:22:33Z,,0,0,09000064819029bf
FDA-2005-N-0453-0031,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 11 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:30:27Z,,0,0,0900006481902a27
FDA-2005-N-0453-0021,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 1 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:19:48Z,,0,0,090000648190293f
FDA-2005-N-0453-0024,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 4 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:22:05Z,,0,0,09000064819029bb
FDA-2005-N-0453-0027,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 7 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:27:57Z,,0,0,0900006481902a10
FDA-2005-N-0453-0033,FDA,FDA-2005-N-0453,Bemotrizinol Dermal Carcinogenicity Summary re Supplement from Ciba Specialty Chemicals,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:34:50Z,,0,0,0900006481902a2b
FDA-2005-N-0453-0026,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 6 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:27:16Z,,0,0,09000064819029e2
FDA-2005-N-0453-0030,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 10 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:29:54Z,,0,0,0900006481902a25
FDA-2005-N-0453-0023,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 3 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:21:25Z,,0,0,09000064819029b9
FDA-2005-N-0453-0032,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 12 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:31:54Z,,0,0,0900006481902a29
FDA-2005-N-0453-0029,FDA,FDA-2005-N-0453,Tab. III A.12 Lifetime Dermal Carcinogenicity Study in Rats Volume 9 of 12 re Supplement from Ciba Specialty Chemicals Corporation,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T16:29:14Z,,0,0,0900006481902a17
FDA-2005-N-0453-0020,FDA,FDA-2005-N-0453,"Initial Determination and Feedback Letter from FDA/CDER to Ciba Specialty Chemicals Corporation (Ciba) (Morgan, Lewis & Bockius LLP) re Time and Extent Application (TEA) Bisoctrizole for use in Over-the-Counter (OTC) Sunscreens",Other,Letter(s),2014-09-03T04:00:00Z,2014,9,2014-09-03T04:00:00Z,,2014-09-03T21:02:03Z,,0,0,090000648185a6e7
FDA-2005-N-0453-0019,FDA,FDA-2005-N-0453,Ciba Specialty Chemicals Corporation Correspondence with FDA Center for Drug Evaluation & Research - Electronic Letter re FDA-2005-N-0453-0002 and FDA-2005-N-0453-0003,Other,Electronic Letter,2014-09-03T04:00:00Z,2014,9,2014-09-03T04:00:00Z,,2014-09-03T20:44:01Z,,0,0,09000064812be491